Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-10-19 Purchase | 2023-10-20 06:50 am | Protalix BioTherapeutics Inc. | PLX | Bashan Dror PRESIDENT AND CEO | 64,516 | $1.4025 | $90,484 | 132,516 (Direct) | View |
| 2023-01-03 Purchase | 2023-01-05 5:08 pm | Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director | 110,000 | $1.4165 | $155,815 | 174,000 (Direct) | View |
| 2022-04-11 Purchase | 2022-04-13 4:05 pm | Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO | 68,000 | $1.5 | $102,000 | 1,153,458 (Indirect Direct) | View |
| 2021-06-02 Sale | 2021-06-03 5:40 pm | Protalix BioTherapeutics Inc. | PLX | Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 918,717 | $2.2737 | $2,088,857 | 3,637,314 (Direct) | View |
| 2020-04-07 Purchase | 2020-04-13 4:05 pm | Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director | 64,000 | $2.426 | $155,264 | 64,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-01 Option Award | 2024-04-03 5:30 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Bashan Dror PRESIDENT AND CEO | 263,960 | $0 | 2,281,934 (Indirect) | View |
| 2023-09-29 Option Award | 2023-10-03 5:00 pm | N/A 2033-09-29 | Protalix BioTherapeutics Inc. | PLX | Boudes Pol F Director | 61,676 | $0 | 61,676 (Direct) | View |
| 2023-09-29 Option Award | 2023-10-03 5:00 pm | N/A 2033-09-29 | Protalix BioTherapeutics Inc. | PLX | Melincoff Gwen A Director | 61,676 | $0 | 61,676 (Direct) | View |
| 2023-09-29 Option Award | 2023-10-03 5:00 pm | N/A 2033-09-29 | Protalix BioTherapeutics Inc. | PLX | Bar-Shalev Amos Director | 61,676 | $0 | 61,676 (Direct) | View |
| 2023-09-29 Option Award | 2023-10-03 5:00 pm | N/A 2033-09-29 | Protalix BioTherapeutics Inc. | PLX | Ben Zvi Shmuel Director | 61,676 | $0 | 61,676 (Direct) | View |
| 2023-09-29 Option Award | 2023-10-03 5:00 pm | N/A 2033-09-29 | Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director | 61,676 | $0 | 61,676 (Direct) | View |
| 2023-09-14 Option Award | 2023-09-15 4:46 pm | N/A 2033-09-14 | Protalix BioTherapeutics Inc. | PLX | Forster Eliot Director | 85,715 | $0 | 85,715 (Direct) | View |
| 2023-08-15 Option Award | 2023-08-17 4:30 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO | 800,000 | $0 | 1,953,458 (Indirect) | View |
| 2023-08-15 Option Award | 2023-08-17 4:30 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO | 201,903 | $0 | 570,000 (Indirect) | View |
| 2023-08-15 Option Award | 2023-08-17 4:30 pm | N/A 2033-08-15 | Protalix BioTherapeutics Inc. | PLX | Hayon Yael VP, Research & Development | 35,115 | $0 | 70,230 (Direct) | View |
| 2023-08-15 Option Award | 2023-08-17 4:30 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Naos Yaron Sr. VP, Operations | 187,344 | $0 | 207,929 (Indirect) | View |
| 2022-09-07 Option Award | 2022-09-09 5:04 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Ben Zvi Shmuel Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:04 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Naos Yaron Sr. VP, Operations | 340,000 | $0 | 340,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:03 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Hayon Yael VP, Research & Development | 250,000 | $0 | 250,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:03 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO | 350,000 | $0 | 350,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:02 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO | 750,000 | $0 | 750,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:02 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Schwartz Aharon Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:01 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Bronfeld Zeev Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:01 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Bar-Shalev Amos Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:01 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Melincoff Gwen A Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 5:00 pm | N/A 2032-09-07 | Protalix BioTherapeutics Inc. | PLX | Boudes Pol F Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-05 4:32 pm | N/A 2032-06-30 | Protalix BioTherapeutics Inc. | PLX | Ben Zvi Shmuel Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-02-25 Option Award | 2022-02-28 5:02 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO | 121,951 | $0 | 368,097 (Indirect) | View |
| 2022-02-25 Option Award | 2022-02-28 5:01 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO | 637,531 | $0 | 1,085,458 (Indirect) | View |
Ownership | 2021-02-16 12:07 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 0 | $0 | 7,372,932 (Direct) | View |
| 2020-08-11 Option Award(A) | 2020-08-14 5:01 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO | 246,146 | $0 | 246,146 (Indirect) | View |
| 2020-08-11 Option Award(A) | 2020-08-14 5:01 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO | 447,927 | $0 | 447,927 (Indirect) | View |
| 2020-08-11 Option Award | 2020-08-13 5:03 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Rubin Eyal Sr. VP and CFO | 246,146 | $0 | 246,146 (Indirect) | View |
| 2020-08-11 Option Award | 2020-08-13 5:02 pm | N/A N/A | Protalix BioTherapeutics Inc. | PLX | Bashan Dror President and CEO | 447,927 | $0 | 447,927 (Indirect) | View |
| 2020-08-11 Option Award | 2020-08-13 5:01 pm | N/A 2030-08-11 | Protalix BioTherapeutics Inc. | PLX | Naos Yaron Sr. VP, Operations | 122,656 | $0 | 122,656 (Direct) | View |
| 2020-07-05 Option Award | 2020-07-08 5:01 pm | N/A 2030-07-05 | Protalix BioTherapeutics Inc. | PLX | Hayon Yael VP, Research & Development | 129,771 | $0 | 129,771 (Direct) | View |
| 2020-06-07 Option Award | 2020-06-08 5:07 pm | N/A 2030-06-07 | Protalix BioTherapeutics Inc. | PLX | Almon Einat Brill SVP, Chief Development Officer | 196,995 | $0 | 196,995 (Direct) | View |